GE HealthCare Technologies (GEHC) Research & Development (2022 - 2026)

GE HealthCare Technologies (GEHC) has 5 years of Research & Development data on file, last reported at $345.0 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development changed 0.29% year-over-year to $345.0 million; the trailing twelve-month figure through Mar 2026 stood at $1.3 billion (down 5.18% YoY), and the FY2025 full-year result was $1.3 billion, down 3.89% from the prior year.
• Research & Development for Q1 2026 stood at $345.0 million, up from $323.0 million in the prior quarter.
• Across five years, Research & Development topped out at $345.0 million in Q1 2026 and bottomed at $238.0 million in Q1 2022.
• The 5-year median for Research & Development is $315.0 million (2023), against an average of $302.8 million.
• The widest annual swing landed in 2023, when Research & Development gained 23.85%; it then decreased 7.65% in 2025.
• A 5-year view of Research & Development shows it stood at $271.0 million in 2022, then rose by 16.24% to $315.0 million in 2023, then rose by 9.21% to $344.0 million in 2024, then declined by 6.1% to $323.0 million in 2025, then advanced by 6.81% to $345.0 million in 2026.
• The last three Research & Development figures came in at $345.0 million (Q1 2026), $323.0 million (Q4 2025), and $292.0 million (Q3 2025), per Business Quant data.

Peer Comparison